HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simona Cabib Selected Research

5-Hydroxytryptophan (5 Hydroxytryptophan)

5/20115-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria.
9/20095-Hydroxytryptophan rescues serotonin response to stress in prefrontal cortex of hyperphenylalaninaemic mice.
6/2008Reduced availability of brain amines during critical phases of postnatal development in a genetic mouse model of cognitive delay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simona Cabib Research Topics

Disease

6Phenylketonurias (Phenylketonuria)
01/2018 - 12/2002
4Intellectual Disability (Idiocy)
01/2021 - 12/2002
1Guanidinoacetate methyltransferase deficiency
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Epilepsy (Aura)
01/2021
1Movement Disorders (Movement Disorder)
01/2021
1Neurodevelopmental Disorders
01/2018
1Fatigue
01/2017
1Body Weight (Weight, Body)
07/2010
1Cognitive Dysfunction
06/2008
1Mood Disorders (Mood Disorder)
05/2008
1Shock
02/2002

Drug/Important Bio-Agent (IBA)

4Phenylalanine (L-Phenylalanine)FDA Link
01/2018 - 12/2002
4Serotonin (5 Hydroxytryptamine)IBA
05/2011 - 12/2002
35-Hydroxytryptophan (5 Hydroxytryptophan)IBA
05/2011 - 06/2008
2Dopamine (Intropin)FDA LinkGeneric
01/2017 - 11/2012
1glycocyamineIBA
01/2021
1CreatineIBA
01/2021
1CorticosteroneIBA
07/2010
1AminesIBA
09/2009
1Biogenic Amines (Biogenic Amine)IBA
06/2008
1Tryptophan (L-Tryptophan)FDA Link
06/2008
1Tyrosine (L-Tyrosine)FDA Link
06/2008
1Neutral Amino AcidsIBA
06/2008
1Homovanillic AcidIBA
02/2002
1salicylhydroxamic acid (SHAM)IBA
02/2002
13,4-Dihydroxyphenylacetic AcidIBA
02/2002

Therapy/Procedure

3Therapeutics
01/2021 - 05/2008